NCT03942302

Brief Summary

Validate a simple clinical tool to evaluate physical activity (the question "How many minutes does it walk per day?" Or equivalent), compared to the rest of the collected physical activity data (PROactive questionnaire and objective physical activity data by means of an accelerometer record) in patients with COPD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2019

Completed
23 days until next milestone

First Posted

Study publicly available on registry

May 8, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

May 8, 2019

Status Verified

May 1, 2019

Enrollment Period

9 months

First QC Date

April 15, 2019

Last Update Submit

May 6, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Minutes of daily walking

    For such effects, the level of physical activity will be determined through a unique question, formulated in 5 different ways, which aims to collect the minutes of physical activity or daily walking minutes. The one that best fits the objective of the study will be selected. The questions that will be asked will be: 1. How many minutes do you walk per day, on average? 2. How many minutes do you walk briskly a day, on average? 3. How many minutes do you walk outside the home on average? 4. How many minutes do you spend doing physical activity a day, on average? 5. How many minutes per day do you engage in moderate to intense physical activity, such as brisk walking, cycling, working in the garden, swimming, dancing, etc., on average?

    During the 7 days that the device has.

Secondary Outcomes (34)

  • Date of inclusion in the study

    day 9

  • Age

    day 9

  • Sex

    day 9

  • Size

    day 9

  • Weight

    day 9

  • +29 more secondary outcomes

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The population under study will be constituted by adult patients diagnosed with COPD. To avoid selection biases, each participating researcher will include in the study the first 10 patients who come to a pulmonology clinic with a clinical diagnosis of COPD and who meet the selection criteria.

You may qualify if:

  • Adult patients, ≥ 40 years.
  • Patients diagnosed with COPD according to the GOLD criteria: FEV1 / FVC postbronchodilator \<0.70 in a spirometry performed in the last 12 months.
  • Smokers or ex-smokers of ≥10 pack-years.
  • Patients with a minimum age in the diagnosis of COPD of at least 6 months.
  • Patients who accept their participation in the study and who have given their informed consent (IC) in writing to participate in it.

You may not qualify if:

  • Patients whose clinical history data are not available.
  • Patients unable to understand the study questionnaires.
  • Patients with physical limitation (not caused by the respiratory disease, eg disability, orthopedic limitation, etc.) and / or psychic that prevents the proper conduct of the study.
  • Patients with other chronic respiratory diseases other than COPD (such as cystic fibrosis, bronchiectasis of origin other than COPD, neoplasia, pneumonia).
  • Patients with serious cardiovascular or neurological diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FUCAP

Barcelona, Catalonia, 08008, Spain

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ferran Morell

    Fundacio Catalana de Pneumologia

    STUDY DIRECTOR

Central Study Contacts

Ester Salmerón

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
9 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

April 15, 2019

First Posted

May 8, 2019

Study Start

March 1, 2019

Primary Completion

December 1, 2019

Study Completion

April 1, 2020

Last Updated

May 8, 2019

Record last verified: 2019-05

Locations